Sign in to view content

Evaluation of Treatment of High Risk Proliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection (ELYSIAN)

Victor Hugo Gonzalez, MD

Video
Published 2018

Related

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results
Pravin U. Dugel, MD
Updates from the Field
2018
Advanced Image Analysis and Machine-Learning Assessment of the Impact of Aflibercept on Anatomic Feature and Flow Dynamics in the PERMEATE Study
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2018
Episode 28: Brolucizumab for wet AMD (HAWK and HARRIER) - Dr. Pravin Dugel
Keyvan Koushan, MD, FRCSC
Member Podcasts

Category: Diabetic Retinopathy

See more